Barclays’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$263K Buy
365,450
+36,061
+11% +$26K ﹤0.01% 3373
2025
Q1
$484K Sell
329,389
-39,887
-11% -$58.6K ﹤0.01% 2865
2024
Q4
$1.64M Sell
369,276
-47,044
-11% -$208K ﹤0.01% 2341
2024
Q3
$1.72M Buy
416,320
+219,304
+111% +$903K ﹤0.01% 2294
2024
Q2
$1.29M Sell
197,016
-93,229
-32% -$608K ﹤0.01% 1977
2024
Q1
$2.53M Sell
290,245
-262,323
-47% -$2.28M ﹤0.01% 1790
2023
Q4
$6.32M Sell
552,568
-26,104
-5% -$299K ﹤0.01% 1333
2023
Q3
$5.57M Buy
578,672
+123,874
+27% +$1.19M ﹤0.01% 1086
2023
Q2
$4.84M Buy
454,798
+121,785
+37% +$1.3M ﹤0.01% 1243
2023
Q1
$3.5M Sell
333,013
-143,186
-30% -$1.51M ﹤0.01% 1285
2022
Q4
$5.9M Sell
476,199
-98,296
-17% -$1.22M ﹤0.01% 1029
2022
Q3
$5.95M Buy
574,495
+453,988
+377% +$4.7M 0.01% 1007
2022
Q2
$1.39M Sell
120,507
-335,591
-74% -$3.87M ﹤0.01% 1829
2022
Q1
$5.74M Buy
456,098
+233,894
+105% +$2.94M ﹤0.01% 1112
2021
Q4
$2.59M Buy
222,204
+6,488
+3% +$75.6K ﹤0.01% 1656
2021
Q3
$2.82M Sell
215,716
-9,639
-4% -$126K ﹤0.01% 1625
2021
Q2
$2.9M Sell
225,355
-217,046
-49% -$2.79M ﹤0.01% 1504
2021
Q1
$4.95M Buy
442,401
+65,173
+17% +$729K ﹤0.01% 1196
2020
Q4
$4.3M Sell
377,228
-114,182
-23% -$1.3M ﹤0.01% 1086
2020
Q3
$4.42M Buy
491,410
+214,377
+77% +$1.93M ﹤0.01% 1031
2020
Q2
$2.86M Buy
277,033
+46,565
+20% +$481K ﹤0.01% 1238
2020
Q1
$2.33M Buy
230,468
+62,652
+37% +$632K ﹤0.01% 1268
2019
Q4
$2.23M Buy
167,816
+70,667
+73% +$941K ﹤0.01% 1801
2019
Q3
$833K Sell
97,149
-51,879
-35% -$445K ﹤0.01% 2356
2019
Q2
$1.63M Sell
149,028
-140,875
-49% -$1.54M ﹤0.01% 1974
2019
Q1
$3.29M Buy
289,903
+72,883
+34% +$826K ﹤0.01% 1229
2018
Q4
$1.88M Buy
217,020
+137,096
+172% +$1.19M ﹤0.01% 1398
2018
Q3
$1.24M Buy
79,924
+67,806
+560% +$1.05M ﹤0.01% 2131
2018
Q2
$194K Sell
12,118
-27,499
-69% -$440K ﹤0.01% 2764
2018
Q1
$511K Sell
39,617
-144,466
-78% -$1.86M ﹤0.01% 2277
2017
Q4
$2.31M Buy
184,083
+177,994
+2,923% +$2.23M ﹤0.01% 1195
2017
Q3
$80K Buy
6,089
+4,602
+309% +$60.5K ﹤0.01% 2785
2017
Q2
$24K Sell
1,487
-3,468
-70% -$56K ﹤0.01% 3218
2017
Q1
$71K Sell
4,955
-11,660
-70% -$167K ﹤0.01% 2976
2016
Q4
$213K Sell
16,615
-522
-3% -$6.69K ﹤0.01% 2271
2016
Q3
$227K Sell
17,137
-199,001
-92% -$2.64M ﹤0.01% 2073
2016
Q2
$2.37M Buy
216,138
+146,103
+209% +$1.6M ﹤0.01% 1028
2016
Q1
$587K Buy
70,035
+25,338
+57% +$212K ﹤0.01% 1663
2015
Q4
$412K Sell
44,697
-62,900
-58% -$580K ﹤0.01% 1761
2015
Q3
$902K Buy
107,597
+26,631
+33% +$223K ﹤0.01% 1465
2015
Q2
$813K Buy
80,966
+68,232
+536% +$685K ﹤0.01% 1580
2015
Q1
$171K Sell
12,734
-4,228
-25% -$56.8K ﹤0.01% 2322
2014
Q4
$214K Sell
16,962
-4,682
-22% -$59.1K ﹤0.01% 2339
2014
Q3
$217K Sell
21,644
-141,028
-87% -$1.41M ﹤0.01% 2286
2014
Q2
$2.05M Buy
162,672
+137,432
+545% +$1.73M ﹤0.01% 1343
2014
Q1
$253K Buy
25,240
+11,039
+78% +$111K ﹤0.01% 2274
2013
Q4
$132K Sell
14,201
-34,416
-71% -$320K ﹤0.01% 2880
2013
Q3
$447K Sell
48,617
-109,855
-69% -$1.01M ﹤0.01% 2176
2013
Q2
$1.32M Buy
+158,472
New +$1.32M ﹤0.01% 1561